Pomerantz LLP is investigating FMC Corporation and some of its executives for potential securities fraud following the company's announcement of significantly lowered Q3 2026 revenue and EBITDA expectations. FMC's updated guidance revealed a revenue range of $65 million to $125 million and a negative adjusted EBITDA between $565 million and $510 million, citing a $625 million to $675 million impact from price reductions and changes in the U.S. sales model. The news caused FMC's stock to plunge over 30% on October 15, 2026. The investigation aims to determine if FMC engaged in unlawful business practices affecting investors.
FMC Corporation shares are trading at USD 6.10 on Pluang as of November 4, 2026, with a 1-day decline of 6.15%. The stock's market capitalization stands at $1.01 billion, reflecting ongoing investor caution. Pluang data shows a nearly balanced order activity with 48% selling and 52% buying interest.
